FrancophonIA/ELRC3.0 huggingface dataset:
English: PritorPlus is available in blisters packs containing 14, 28, 30, 56, 90 or 98 tablets, or unit dose blister packs containing 28 x 1 tablets.
Slovenian: Zdravilo PritorPlus je na voljo v pretisnih omotih po 14, 28, 30, 56, 90, 98 tablet ali pretisnih omotih za enkratni odmerek po 28 x 1 tableta.
English: Periodic monitoring of serum potassium and ECG is recommended when PritorPlus is administered with medicinal products affected by serum potassium disturbances (e.g. digitalis glycosides, antiarrhythmics) and the following torsades de pointes inducing medicinal products (which include some antiarrhythmics), hypokalaemia being a predisposing factor to torsades de pointes.
Slovenian: Priporočamo periodično spremljanje ravni kalija v serumu in EKG, kadar dajemo zdravilo PritorPlus hkrati z zdravili, na delovanje katerih vplivajo motnje serumskega kalija (npr. z glikozidi digitalisa ali antiaritmiki).
English: INFORMATION IN BRAILLE PritorPlus 80 mg/25 mg
Slovenian: PODATKI V BRAILLOVI PISAVI PritorPlus 80 mg/25 mg
English: Japanese patients are more likely to experience these adverse reactions.
Slovenian: Preobčutljivostne reakcije so verjetnejše pri bolnikih, ki imajo omenjena obolenja v anamnezi.
English: Lupus-like syndrome, photosensitivity reactions, skin vasculitis,
Slovenian: lupusu podoben sindrom, fotosenzibilne reakcije, kožni vaskulitis, toksična epidermalna nekroliza, multiformni eritem
English: The hyperglycaemic effect of beta-blockers and diazoxide may be enhanced by thiazides.
Slovenian: Tiazidi lahko povečano hiperglikemični učinek zaviralcev adrenergičnih receptorjev beta in diazoksida.
English: - Hypokalaemia
Slovenian: Hipokaliemija
English: Common side effects (may affect up to 1 in 10 people): Dizziness
Slovenian: Pogosti neželeni učinki (pojavijo se lahko pri največ 1 od 10 bolnikov): omotica.
English: NAME OF THE MEDICINAL PRODUCT PritorPlus 80 mg/25 mg tablets
Slovenian: IME ZDRAVILA PritorPlus 80 mg/25 mg tablete
English: Yellow and white oval shaped tablet of 6.2 mm engraved with the code 'H9'.
Slovenian: Rdeča in bela ovalna, dvoslojna 6,2 mm tableta z vtisnjeno kodno številko 'H9'.
English: Thiazide diuretics may increase serum calcium levels due to the decreased excretion.
Slovenian: Tiazidni diuretiki lahko zaradi manjšega izločanja povečajo raven kalcija v serumu.
English: INFORMATION IN BRAILLE PritorPlus 40 mg/12.5 mg
Slovenian: PODATKI V BRAILLOVI PISAVI PritorPlus 40 mg/12,5 mg
English: EU/1/02/215/001 14 tablets EU/1/02/215/002 28 tablets EU/1/02/215/003 28 x 1 tablets EU/1/02/215/013 30 tablets EU/1/02/215/004 56 tablets EU/1/02/215/011 90 tablets EU/1/02/215/005 98 tablets
Slovenian: EU/1/02/215/001 14 tablet EU/1/02/215/002 28 tablet EU/1/02/215/003 28 x 1 tableta EU/1/02/215/013 30 tablet EU/1/02/215/004 56 tablet EU/1/02/215/011 90 tablet EU/1/02/215/005 98 tablet
English: The other ingredients are lactose monohydrate, magnesium stearate, maize starch, meglumine, microcrystalline cellulose, povidone, red iron oxide (E172), sodium hydroxide, sodium starch glycollate (type A), sorbitol (E420).
Slovenian: Druge sestavine zdravila so laktoza monohidrat, magnezijev stearat, koruzni škrob, meglumin, mikrokristalna celuloza, povidon (K25), rdeč železov oksid (E172), natrijev hidroksid, natrijev karboksimetilškrob (vrsta A) in sorbitol (E420).
English: - Hyponatraemia and hypochloraemic alkalosis There is no evidence that PritorPlus would reduce or prevent diuretic-induced hyponatraemia.
Slovenian: Ni podatkov, ki bi kazali, da zdravilo PritorPlus zmanjša ali prepreči hiponatriemijo, ki jo povzročajo diuretiki.
English: EU/1/02/215/006 14 tablets EU/1/02/215/007 28 tablets EU/1/02/215/008 28 x 1 tablets EU/1/02/215/014 30 tablets EU/1/02/215/009 56 tablets EU/1/02/215/012 90 tablets EU/1/02/215/010 98 tablets
Slovenian: EU/1/02/215/006 14 tablet EU/1/02/215/007 28 tablet EU/1/02/215/008 28 x 1 tableta EU/1/02/215/014 30 tablet EU/1/02/215/009 56 tablet EU/1/02/215/012 90 tablet EU/1/02/215/010 98 tablet
English: Protect your skin from sun exposure and UV rays while taking PritorPlus.
Slovenian: Med jemanjem zdravila PritorPlus zaščitite kožo pred izpostavljenostjo soncu in UV-žarkom.
English: Latent diabetes mellitus may become manifest during thiazide therapy.
Slovenian: Med zdravljenjem s tiazidi se lahko razvijejo klinični znaki latentnega diabetesa mellitusa.
English: The other ingredients are lactose monohydrate, magnesium stearate, maize starch, meglumine, microcrystalline cellulose, povidone, yellow iron oxide (E172), sodium hydroxide, sodium starch glycollate (type A), sorbitol (E420).
Slovenian: Druge sestavine zdravila so laktoza monohidrat, magnezijev stearat, koruzni škrob, meglumin, mikrokristalna celuloza, povidon (K25), rumen železov oksid (E172), natrijev hidroksid, natrijev karboksimetilškrob (vrsta A) in sorbitol (E420).
English: PritorPlus fixed dose combination (80 mg telmisartan/25 mg hydrochlorothiazide) is indicated in adults whose blood pressure is not adequately controlled on PritorPlus 80 mg/12.5 mg (80 mg telmisartan/12.5 mg hydrochlorothiazide) or adults who have been previously stabilised on telmisartan and hydrochlorothiazide given separately.
Slovenian: Zdravilo PritorPlus, fiksna kombinacija (80 mg telmisartana in 25 mg hidroklorotiazida), je indicirano za odrasle, pri katerih krvnega tlaka ne moremo ustrezno uravnati z zdravilom PritorPlus 80 mg/12,5 mg (80 mg telmisartana in 12,5 mg hidroklorotiazida) ali za bolnike, ki jemljejo telmisartan in hidroklorotiazid posebej in imajo ustaljen krvni tlak.
English: PritorPlus 80 mg/12.5 mg tablets Each tablet contains 80 mg telmisartan and 12.5 mg hydrochlorothiazide.
Slovenian: PritorPlus 80 mg/12,5 mg tablete Ena tableta vsebuje 80 mg telmisartana in 12,5 mg hidroklorotiazida.
English: PritorPlus 40 mg/12.5 mg tablets Each tablet contains 40 mg telmisartan and 12.5 mg hydrochlorothiazide.
Slovenian: PritorPlus 40 mg/12,5 mg tablete Ena tableta vsebuje 40 mg telmisartana in 12,5 mg hidroklorotiazida.
English: Psychiatric disorders Not known:
Slovenian: Psihiatrične motnje Neznana:
English: - Heart trouble.
Slovenian: želodčne težave
English: Weakness
Slovenian: oslabelost
English: Non-melanoma skin cancer (Basal cell carcinoma and Squamous cell carcinoma) Blood and lymphatic system disorders Rare:
Slovenian: nemelanomski kožni rak (bazalnocelični karcinom in ploščatocelični karcinom)
English: Talk to your doctor before taking PritorPlus:
Slovenian: Pred začetkom jemanja zdravila PritorPlus se posvetujte z zdravnikom:
English: Medicines that may increase blood potassium levels such as potassium-sparing diuretics, potassium supplements, salt substitutes containing potassium, ACE inhibitors, cyclosporin (an immunosuppressant drug) and other medicinal products such as heparin sodium (an anticoagulant).
Slovenian: Zdravila, ki lahko povečajo raven kalija ali povzročijo hiperkaliemijo (npr. zaviralci ACE; diuretiki, ki varčujejo s kalijem; kalijevi pripravki; nadomestki soli, ki vsebujejo kalij; ciklosporin ali druga zdravila, kot je natrijev heparinat)
English: Not applicable.
Slovenian: Ukrepati ni potrebno.
English: Hepatic function abnormal / liver disorder
Slovenian: Nenormalno delovanje jeter ali jetrna bolezen
English: Exacerbation or activation of systemic lupus erythematosus has been reported with the use of thiazide diuretics, including hydrochlorothiazide.
Slovenian: Pri uporabi tiazidnih diuretikov vključno z hidroklorotiazidom poročajo o poslabšanju ali aktiviranju sistemskega eritematoznega lupusa.
English: Nervous system disorders Rare:
Slovenian: Bolezni živčevja Redki:
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 80 mg telmisartan and 25 mg hydrochlorothiazide.
Slovenian: KAKOVOSTNA IN KOLIČINSKA SESTAVA Enatableta vsebuje 80 mg telmisartana in 25 mg hidroklorotiazida.
English: PritorPlus 80 mg/25 mg may be administered once daily in patients whose blood pressure is not adequately controlled by PritorPlus 80 mg/12.5 mg or in patients who have been previously stabilised on telmisartan and hydrochlorothiazide given separately.
Slovenian: • Zdravilo PritorPlus 80 mg/25 mg lahko dajemo enkrat na dan bolnikom, pri katerih krvnega tlaka ne moremo ustrezno uravnati z zdravilom PritorPlus 80 mg/12,5 mg, ali bolnikom, ki jemljejo telmisartan in hidroklorotiazid posebej in imajo ustaljen krvni tlak.
English: INFORMATION IN BRAILLE PritorPlus 80 mg/12.5 mg
Slovenian: PODATKI V BRAILLOVI PISAVI PritorPlus 80 mg/12,5 mg
English: The overall incidence and pattern of adverse reactions reported with PritorPlus 80 mg/25 mg was comparable with PritorPlus 80 mg/12.5 mg. A dose-relationship of adverse reactions was not established and they showed no correlation with gender, age or race of the patients.
Slovenian: Celokupna pogostnost in vzorec neželenih učinkov, o katerih so poročali v zvezi z zdravilom PritorPlus 80 mg/25 mg, je primerljiva s pogostnostjo neželenih učinkov zdravila PritorPlus 80 mg/12,5 mg.
English: Aplastic anaemia, haemolytic anaemia, bone marrow failure, leukopenia, neutropenia, agranulocytosis,
Slovenian: trombocitopenija (včasih s purpuro) aplastična anemija, hemolitična anemija, odpoved kostnega mozga, levkopenija, nevtropenija, agranulocitoza
English: PritorPlus is used to treat high blood pressure (essential hypertension) in adults whose blood pressure is not adequately controlled by PritorPlus 80/12.5 mg or in adults who have been previously stabilised by telmisartan and hydrochlorothiazide given separately.
Slovenian: Zdravilo PritorPlus je namenjeno za zdravljenje visokega krvnega tlaka (esencialne hipertenzije) pri odraslih, pri katerih s samim zdravilom PritorPlus 80 mg/12,5 mg krvnega tlaka ne moremo primerno uravnati ali za bolnike, ki jemljejo telmisartan in hidroklorotiazid posebej in imajo ustaljen krvni tlak.
English: Hypotension, orthostatic hypotension Respiratory, thoracic and mediastinal disorders Uncommon: Rare:
Slovenian: hipotenzija, ortostatska hipotenzija Bolezni dihal, prsnega koša in mediastinalnega prostora Občasni:
English: Most cases of hepatic function abnormal / liver disorder from post-marketing experience with telmisartan occurred in Japanese patients.
Slovenian: O večini primerov nenormalnega delovanja jeter ali jetrne bolezni so v obdobju po začetku trženja telmisartana poročali pri japonskih bolnikih, pri katerih tudi sicer obstaja večja verjetnost teh neželenih reakcij.
English: Although hypokalaemia may develop with the use of thiazide diuretics, concurrent therapy with telmisartan may reduce diuretic-induced hypokalaemia.
Slovenian: Sočasno jemanje telmisartana in tiazidnih diuretikov zmanjšuje možnost razvoja hipokaliemije, ki jo povzročajo tiazidni diuretiki.
English: In the PRoFESS trial, an increased incidence of sepsis was observed with telmisartan compared with placebo.
Slovenian: V primerjavi s placebom se je v raziskavi PRoFESS med zdravljenjem s telmisartanom povečala pojavnost sepse.
English: PritorPlus 80 mg/25 mg tablets are yellow and white, oval-shaped, two-layer tablets engraved with the code 'H9'.
Slovenian: Tablete zdravila PritorPlus 80 mg/25 mg so rumene in bele, ovalne, dvoslojne, z vtisnjeno kodno številko 'H9'.
English: Each tablet contains 80 mg telmisartan and 25 mg hydrochlorothiazide.
Slovenian: Ena tableta vsebuje 80 mg telmisartana in 25 mg hidroklorotiazida.
English: Symptomatic hypotension, especially after the first dose, may occur in patients who are volume and/or sodium depleted by vigorous diuretic therapy, dietary salt restriction, diarrhoea or vomiting.
Slovenian: Pri bolnikih z zmanjšanim volumnom krvi in/ali zmanjšano količino natrija zaradi intenzivnega diuretičnega zdravljenja, uživanja hrane z omejeno količino soli ter driske ali bruhanja se zlasti po prvem odmerku lahko pojavi simptomatska hipotenzija.
English: Each tablet contains 40 mg telmisartan and 12.5 mg hydrochlorothiazide.
Slovenian: Ena tableta vsebuje 40 mg telmisartana in 12,5 mg hidroklorotiazida.
English: Thiazides should be discontinued before carrying out tests for parathyroid function.
Slovenian: Pred preiskavo delovanja obščitnice je treba tiazideukiniti.
English: Studies with hydrochlorothiazide have shown equivocal evidence for a genotoxic or carcinogenic effect in some experimental models.
Slovenian: Raziskave o hidroklorotiazidu so v nekaterih eksperimentalnih modelih nesporno potrdile genotoksični ali kancerogeni učinek, vendar obsežne izkušnje z uporabo hidroklorotiazida pri ljudeh ne kažejo na povezavo med njegovo uporabo in novotvorbami.
English: Sialadenitis
Slovenian: astenija
English: Nausea
Slovenian: nemir
English: PritorPlus 80 mg/12.5 mg tablets Red and white oval shaped two layer tablet of 6.2 mm engraved with the code number 'H8'.
Slovenian: PritorPlus 80 mg/12,5 mg tablete Rdeča in bela ovalna, dvoslojna 6,2 mm tableta z vtisnjeno kodno številko 'H8'.
English: For the foetotoxic potential of the telmisartan/hydrochlorothiazide combination see section 4.6.
Slovenian: Podatki o možnih fetotoksičnih učinkih kombinacije telmisartana in hidroklorotiazida so v poglavju
English: Syncope, paraesthesia Insomnia, sleep disorders
Slovenian: nespečnost, motnje spanja
English: There is an increased risk of severe hypotension and renal insufficiency when patients with bilateral renal artery stenosis or stenosis of the artery to a single functioning kidney are treated with medicinal products that affect the renin-angiotensin-aldosterone system.
Slovenian: Pri bolnikih z obojestransko zožitvijo ledvične arterije ali arterije samo ene delujoče ledvice, zdravljenje z zdravili, ki delujejo na renin-angiotenzin-aldosteronski sistem, poveča nevarnost hude hipotenzije in zmanjšanja delovanja ledvic.
English: Hypochloraemic alkalosis
Slovenian: Hiponatriemija in hipokloremična alkaloza
English: Therefore, in these patients blood glucose monitoring should be considered; a dose adjustment of insulin or antidiabetics may be required, when indicated.
Slovenian: Če za to obstaja indikacija, je včasih treba prilagoditi odmerek insulina ali peroralnega antidiabetika.
English: PritorPlus 40 mg/12.5 mg tablets Red and white oval shaped two layer tablet of 5.2 mm engraved with the code number 'H4'.
Slovenian: PritorPlus 40 mg/12,5 mg tablete Rdeča in bela ovalna, dvoslojna 5,2 mm tableta z vtisnjeno kodno številko 'H4'.
English: Each tablet contains 80 mg telmisartan and 12.5 mg hydrochlorothiazide.
Slovenian: Ena tableta vsebuje 80 mg telmisartana in 12,5 mg hidroklorotiazida.
English: Suggested measures include induction of emesis and/or gastric lavage.
Slovenian: Priporočena ukrepa sta povzročitev bruhanja ali izpiranje želodca ali oba.
English: - Hyperkalaemia
Slovenian: hiperkaliemija
English: Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with angiotensin converting enzyme inhibitors.
Slovenian: Za sočasno jemanje litija in zaviralcev angiotenzinske konvertaze (zaviralci ACE) poročajo o reverzibilnem povečanju serumskih koncentracij litija in njegove toksičnosti.
English: PritorPlus 80 mg/12.5 mg tablets
Slovenian: PritorPlus 40 mg/12,5 mg tablete PritorPlus 80 mg/12,5 mg tablete
English: Cholestyramine and colestipol resins
Slovenian: Holestiramin in holestipolove smole
English: - class Ia antiarrythmics (e.g. quinidine, hydroquinidine, disopyramide) - class III antiarrythmics (e.g. amiodarone, sotalol, dofetilide, ibutilide) - some antipsychotics (e.g. thioridazine, chlorpromazine, levomepromazine, trifluoperazine,
Slovenian: Enako velja za jemanje z naslednjimi zdravili, ki lahko povzročijo torsades de pointes (med njimi tudi z nekaterimi antiaritmiki), ker je hipokaliemija predispozicijski dejavnik za pojav torsades de pointes: antiaritmiki skupine Ia (npr. kinidin, hidrokinidin, dizopiramid), antiaritmiki skupine III (npr. amiodaron, sotalol, dofetilid, ibutilid), nekateri antipsihotiki: (npr. tioridazin, klorpromazin, levomepromazin, trifluorperazin, ciamemazin, sulpirid, sultoprid, amisulprid, tiaprid, pimozid, haloperidol, droperidol), drugo: (npr. bepridil, cisaprid, difemanil, eritromicin iv., halofantrin, mizolastin, pentamidin, sparfloksacin, terfenadin, vinkamin iv.).
English: Hydrochlorothiazide is 68 % protein bound in the plasma and its apparent volume of distribution is 0.83 - 1.14 l/kg.
Slovenian: Njegov navidezen volumen porazdelitve je 0,83 do 1,14 l/kg.
English: Upper respiratory tract infection (e.g. sore throat, inflamed sinuses, common cold), urinary tract infections, deficiency in red blood cells (anaemia), high potassium levels, slow heart rate (bradycardia), kidney impairment including acute kidney failure, weakness, cough.
Slovenian: Občasni neželeni učinki (pojavijo se lahko pri največ 1 od 100 bolnikov): okužba zgornjih dihal (npr.boleče žrelo, vnetje sinusov, prehlad), okužbe sečil, pomanjkanje rdečih krvničk (anemija), visoka raven kalija, počasen srčni utrip (bradikardija), ledvična okvara, tudi akutna ledvična odpoved; oslabelost, kašelj.
English: Low platelet count (thrombocytopenia), increase in certain white blood cells (eosinophilia), serious allergic reaction (e.g. hypersensitivity, anaphylactic reaction, drug rash), low blood sugar levels (in diabetic patients), upset stomach, eczema (a skin disorder), arthrosis, inflammation of the tendons, decreased haemoglobin (a blood protein), somnolence.
Slovenian: Redki neželeni učinki (pojavijo se lahko pri največ 1 od 1.000 bolnikov): majhno število trombocitov (trombocitopenija), povečano število nekaterih belih krvničk (eozinofilija), resne alergijske reakcije (npr. preobčutljivost, anafilaktična reakcija, medikamentni izpuščaj), nizka raven krvnega sladkorja (pri bolnikih s sladkorno boleznijo), želodčne težave, ekcem (kožna bolezen), artroza, vnetje kit, znižana raven hemoglobina (krvne beljakovine), zaspanost.
English: Potassium-sparing diuretics, potassium supplements or potassium-containing salt substitutes should be co-administered cautiously with PritorPlus (see section 4.5).
Slovenian: Če se bolniki zdravijo z zdravilom PritorPlus, moramo biti previdni pri sočasnem dajanju diuretikov, ki varčujejo s kalijem, kalijevih pripravkov ali nadomestkov soli, ki vsebujejo kalij (glejte poglavje 4.5).
English: PritorPlus 80 mg/25 mg tablets telmisartan/hydrochlorothiazide
Slovenian: PritorPlus 80 mg/25 mg tablete telmisartan/hidroklorotiazid
English: NAME OF THE MEDICINAL PRODUCT PritorPlus 80 mg/25 mg tablets telmisartan/hydrochlorothiazide
Slovenian: IME ZDRAVILA PritorPlus 80 mg/25 mg tablete telmisartan/hidroklorotiazid
English: There is no clinical experience with PritorPlus in patients with hepatic impairment.
Slovenian: Z zdravilom PritorPlus pri bolnikih z zmanjšanim delovanjem jeter ni izkušenj.
English: PritorPlus 80 mg/12.5 mg tablets are red and white, oval-shaped, two-layer tablets engraved with the code number 'H8'.
Slovenian: Tablete zdravila PritorPlus 80 mg/12,5 mg so rdeče in bele, ovalne, dvoslojne, z vtisnjeno kodno številko 'H8'.
English: Angioedema (also with fatal outcome), erythema, pruritus, rash, hyperhidrosis, urticaria
Slovenian: angioedem (lahko povzroči tudi smrt), eritem, pruritus, izpuščaj, hiperhidroza, urtikarija Bolezni mišično-skeletega sistema, vezivnega tkiva in kosti Občasni:
English: Dizziness or drowsiness may occasionally occur when taking PritorPlus.
Slovenian: Zdravilo PritorPlus lahko včasih povzroči omotico ali dremavost.
English: Prompt medical or surgical treatments may need to be considered if the intraocular pressure remains uncontrolled.
Slovenian: Če se očesni tlak ne uravna, je lahko potrebno takojšnje zdravljenje z zdravili ali operativno zdravljenje.
English: PritorPlus 40 mg/12.5 mg tablets are red and white, oval-shaped two-layer tablets engraved with the code number 'H4'.
Slovenian: Tablete zdravila PritorPlus 40 mg/12,5 mg so rdeče in bele, ovalne, dvoslojne, z vtisnjeno kodno številko 'H4'.
English: Inflammation of the salivary gland, skin and lip cancer (non-melanoma skin cancer), decreases in the number (or even lack) of cells in the blood, including low red and white blood cell count, , serious allergic reactions (e.g. hypersensitivity, anaphylactic reaction), decreased or loss of appetite, restlessness, light-headedness, blurred or yellowing of vision, decrease in vision and eye pain (possible signs of acute myopia or acute-angle closure glaucoma), inflammation of blood vessels (vasculitis necrotising), inflamed pancreas, upset stomach, yellowing of the skin or eyes (jaundice), lupus-like syndrome (a condition mimicking a disease called systemic lupus erythematosus where the body's immune system attacks the body); skin disorders such as inflamed blood vessels in the skin, increased sensitivity to sunlight, rash, redness of the skin, blistering of the lips, eyes or mouth, skin peeling, fever (possible signs of erythema multiforme) weakness, kidney inflammation or impaired kidney function, glucose in the urine (glycosuria), fever, impaired electrolyte balance, high blood cholesterol levels, decreased blood volume, increased blood levels of glucose, difficulties in controlling blood/ urine levels of glucose in patients with a diagnosis of diabetes mellitus, or fat in the blood.
Slovenian: Neželeni učinki neznane pogostnosti (ni mogoče oceniti iz razpoložljivih podatkov): vnetje žleze slinavke, kožni rak in rak ustnice (nemelanomski kožni rak), zmanjšanje števila (ali celo pomanjkanje) krvnih celic, tudi majhno število rdečih in belih krvničk; resne alergijske reakcije (npr. preobčutljivost, anafilaktična reakcija), zmanjšan tek ali izguba teka, nemir, vrtoglavica, zamegljen vid ali rumenkasta obarvanost, poslabšan vid in očesna bolečina (možna znaka akutne miopije ali akutnega glavkoma zaprtega zakotja), vnetje žil (nekrotizirajoči vaskulitis), vnetje trebušne slinavke, želodčne težave, porumenelost kože ali oči (zlatenica), lupusu podoben sindrom (bolezensko stanje, ki je podobno sistemskemu eritematoznemu lupusu, pri kateri telo napade človekov lastni imunski sistem), kožne motnje, kot so vnetje žil v koži; povečana občutljivost za sončno svetlobo, izpuščaj, pordelost kože, pojav mehurčkov na ustnicah, očeh ali v ustih, luščenje kože, povišana telesna temperatura (možen znak za multiformni eritem), oslabelost, vnetje ledvic ali okvara ledvičnega delovanja, sladkor v urinu (glikozurija), zvišana telesna temperatura, moteno elektrolitsko ravnovesje, visoka raven holesterola, zmanjšan krvni volumen, povečana raven glukoze v krvi, težave pri uravnavanju ravni glukoze v krvi ali urinu pri bolnikih s sladkorno boleznijo, ali maščob v krvi.
English: NAME OF THE MEDICINAL PRODUCT PritorPlus 40 mg/12.5 mg tablets telmisartan/hydrochlorothiazide
Slovenian: IME ZDRAVILA PritorPlus 40 mg/12,5 mg tablete telmisartan/hidroklorotiazid
English: Blood uric acid increased
Slovenian: zvišana raven sečne kisline v krvi
English: PritorPlus 40 mg/12.5 mg tablets telmisartan/hydrochlorothiazide
Slovenian: PritorPlus 40 mg/12,5 mg tablete telmisartan/hidroklorotiazid
English: Stomach discomfort Skin and subcutaneous tissue disorders Rare:
Slovenian: Bolezni kože in podkožja Redki:
English: Therefore, the use of PritorPlus is not recommended.
Slovenian: Sočasno dajanje litija in zdravila PritorPlus ne priporočamo.
English: NAME OF THE MEDICINAL PRODUCT PritorPlus 80 mg/12.5 mg tablets telmisartan/hydrochlorothiazide
Slovenian: IME ZDRAVILA PritorPlus 80 mg/12,5 mg tablete telmisartan/hidroklorotiazid
English: PritorPlus is not recommended for mothers who are breast-feeding, and your doctor may choose another treatment for you if you wish to breast-feed.
Slovenian: Zdravila PritorPlus ne priporočajo materam, ki dojijo.